* Pharmaxis Ltd., of Sydney, Australia, said the first patients have been dosed in a Phase II trial of Bronchitol, a mucus-clearing agent, in cystic fibrosis. After the first two weeks of treatment, patients will be randomized to begin testing different …
No comments:
Post a Comment